生存时间-话题@MedSci

#生存时间#

26篇内容 | 1473人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1756013, encodeId=e7d51e5601327, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, objectTitle=我不要你觉得，我要我觉得！即使自评，有心理困扰的乳腺癌患者生存时间缩短28年！死亡风险上升45%！, objectType=article, longId=292480, objectId=37da29248055, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37da29248055, replyNumber=0, likeNumber=87, createdTime=2022-07-04, rootId=0, userName=lilili1116, userId=03a637065096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37da29248055, moduleTitle=我不要你觉得，我要我觉得！即使自评，有心理困扰的乳腺癌患者生存时间缩短28年！死亡风险上升45%！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37da29248055)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1756014, encodeId=d1321e56014d4, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, objectTitle=中国患者研究：祸福相倚！用免疫检查点抑制剂有皮肤免疫相关不良事件，生存时间竟或翻倍？, objectType=article, longId=726357, objectId=8d0fe2635779, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d0fe2635779, replyNumber=0, likeNumber=103, createdTime=2022-08-26, rootId=0, userName=lilili1116, userId=03a637065096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d0fe2635779, moduleTitle=中国患者研究：祸福相倚！用免疫检查点抑制剂有皮肤免疫相关不良事件，生存时间竟或翻倍？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d0fe2635779)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1756015, encodeId=84e61e56015aa, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, objectTitle=ASCO2022：纳武利尤单抗能显著增加高危肌层浸润性尿路上皮癌患者无病生存时间, objectType=article, longId=728372, objectId=b310e283729d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b310e283729d, replyNumber=0, likeNumber=63, createdTime=2022-06-10, rootId=0, userName=lilili1116, userId=03a637065096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b310e283729d, moduleTitle=ASCO2022：纳武利尤单抗能显著增加高危肌层浸润性尿路上皮癌患者无病生存时间, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b310e283729d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1756011, encodeId=4af21e5601124, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, objectTitle=Liver Cancer：肝细胞癌患者免疫检查点抑制剂（ICI）治疗期间使用抗生素缩短生存时间, objectType=article, longId=216031, objectId=4df92160316b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4df92160316b, replyNumber=0, likeNumber=87, createdTime=2022-07-16, rootId=0, userName=lilili1116, userId=03a637065096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4df92160316b, moduleTitle=Liver Cancer：肝细胞癌患者免疫检查点抑制剂（ICI）治疗期间使用抗生素缩短生存时间, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4df92160316b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1756012, encodeId=25771e560129e, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, objectTitle=Clin Cancer Res：nivolumab + ipilimumab对比舒尼替尼治疗晚期肾细胞癌（aRCC）患者后的无治疗生存时间（TFS）对比：来自Check- Mate 214研究结果, objectType=article, longId=220254, objectId=cfa922025489, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfa922025489, replyNumber=0, likeNumber=74, createdTime=2022-06-04, rootId=0, userName=lilili1116, userId=03a637065096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfa922025489, moduleTitle=Clin Cancer Res：nivolumab + ipilimumab对比舒尼替尼治疗晚期肾细胞癌（aRCC）患者后的无治疗生存时间（TFS）对比：来自Check- Mate 214研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfa922025489)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1756010, encodeId=1c501e5601040, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, objectTitle=Clin Trans Gastroenterology：性别相关的基因表达改变与食管癌的生存时间相关, objectType=article, longId=206495, objectId=e9f62064953a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9f62064953a, replyNumber=0, likeNumber=86, createdTime=2021-08-25, rootId=0, userName=lilili1116, userId=03a637065096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9f62064953a, moduleTitle=Clin Trans Gastroenterology：性别相关的基因表达改变与食管癌的生存时间相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9f62064953a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1756009, encodeId=244c1e560096b, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, objectTitle=Chest：过敏性肺炎的影像学表型与不同生存时间和肺功能轨迹相关, objectType=article, longId=149351, objectId=4d7b1493513c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d7b1493513c, replyNumber=0, likeNumber=77, createdTime=2018-10-02, rootId=0, userName=lilili1116, userId=03a637065096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d7b1493513c, moduleTitle=Chest：过敏性肺炎的影像学表型与不同生存时间和肺功能轨迹相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d7b1493513c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1756007, encodeId=9f971e56007dd, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, objectTitle=JAMA Oncology：CD8+肿瘤浸润淋巴细胞与卵巢癌生存时间的关系, objectType=article, longId=123651, objectId=92f0123651ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92f0123651ad, replyNumber=0, likeNumber=83, createdTime=2018-11-06, rootId=0, userName=lilili1116, userId=03a637065096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92f0123651ad, moduleTitle=JAMA Oncology：CD8+肿瘤浸润淋巴细胞与卵巢癌生存时间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92f0123651ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1756006, encodeId=76bb1e5600641, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, objectTitle=Heart：主动脉瓣置换术会延长严重返流和低射血分数患者的生存时间吗？, objectType=article, longId=119724, objectId=337c119e24e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=337c119e24e1, replyNumber=0, likeNumber=101, createdTime=2018-08-17, rootId=0, userName=lilili1116, userId=03a637065096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=337c119e24e1, moduleTitle=Heart：主动脉瓣置换术会延长严重返流和低射血分数患者的生存时间吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=337c119e24e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1756008, encodeId=85c61e56008eb, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, objectTitle=J Clin Periodontol：利用生存时间预测牙周预后的预测模型, objectType=article, longId=128094, objectId=60cc12809453, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60cc12809453, replyNumber=0, likeNumber=75, createdTime=2018-07-02, rootId=0, userName=lilili1116, userId=03a637065096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60cc12809453, moduleTitle=J Clin Periodontol：利用生存时间预测牙周预后的预测模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60cc12809453)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1756002, encodeId=93401e560028f, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, objectTitle=Gut：IRTKS与胃癌进展和患者生存时间相关, objectType=article, longId=103310, objectId=3553103310af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3553103310af, replyNumber=0, likeNumber=59, createdTime=2017-08-12, rootId=0, userName=lilili1116, userId=03a637065096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3553103310af, moduleTitle=Gut：IRTKS与胃癌进展和患者生存时间相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3553103310af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1756005, encodeId=78911e5600531, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, objectTitle=β受体拮抗剂是否可以延长晚期HER2阴性乳腺癌患者生存时间？, objectType=article, longId=113380, objectId=f8ed113380c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8ed113380c7, replyNumber=0, likeNumber=81, createdTime=2018-06-25, rootId=0, userName=lilili1116, userId=03a637065096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8ed113380c7, moduleTitle=β受体拮抗剂是否可以延长晚期HER2阴性乳腺癌患者生存时间？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8ed113380c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1756000, encodeId=5ce31e560002b, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, objectTitle=Clin Gastroenterol H：雌激素替代疗法降低女性肝癌患者的风险和增加生存时间！, objectType=article, longId=100693, objectId=121e1006930e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=121e1006930e, replyNumber=0, likeNumber=115, createdTime=2017-06-15, rootId=0, userName=lilili1116, userId=03a637065096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=121e1006930e, moduleTitle=Clin Gastroenterol H：雌激素替代疗法降低女性肝癌患者的风险和增加生存时间！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=121e1006930e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1756001, encodeId=e8b31e56001e5, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, objectTitle=J CLIN ONCOL：阿司匹林等非甾体类抗炎药物的使用时间与结直肠癌患者的肿瘤标志物与生存时间之间的关系, objectType=article, longId=102141, objectId=66ff1021417d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66ff1021417d, replyNumber=0, likeNumber=81, createdTime=2017-10-12, rootId=0, userName=lilili1116, userId=03a637065096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66ff1021417d, moduleTitle=J CLIN ONCOL：阿司匹林等非甾体类抗炎药物的使用时间与结直肠癌患者的肿瘤标志物与生存时间之间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66ff1021417d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1756003, encodeId=8c581e560039a, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, objectTitle=Nature：生存时间延长67%！科学家瞄准肿瘤微环境，找到治疗胶质母细胞瘤的关键基因！, objectType=article, longId=105862, objectId=ae3810586279, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae3810586279, replyNumber=0, likeNumber=82, createdTime=2018-01-23, rootId=0, userName=lilili1116, userId=03a637065096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae3810586279, moduleTitle=Nature：生存时间延长67%！科学家瞄准肿瘤微环境，找到治疗胶质母细胞瘤的关键基因！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae3810586279)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1756004, encodeId=a34f1e560046a, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, objectTitle=JAMA Surg：辅助化疗与胃癌患者生存时间的关系, objectType=article, longId=107205, objectId=63a810e2056d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63a810e2056d, replyNumber=0, likeNumber=88, createdTime=2017-08-11, rootId=0, userName=lilili1116, userId=03a637065096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63a810e2056d, moduleTitle=JAMA Surg：辅助化疗与胃癌患者生存时间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63a810e2056d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755999, encodeId=4bbf1e559995d, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, objectTitle=J CLIN ONCOL：肥胖肾癌患者生存时间更久？！, objectType=article, longId=77187, objectId=954ce718789, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=954ce718789, replyNumber=0, likeNumber=95, createdTime=2017-07-28, rootId=0, userName=lilili1116, userId=03a637065096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=954ce718789, moduleTitle=J CLIN ONCOL：肥胖肾癌患者生存时间更久？！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=954ce718789)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755993, encodeId=a7fe1e5599324, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, objectTitle=JCO：埃罗替尼不能延长NSCLC无病生存时间, objectType=article, longId=56663, objectId=7ba1566636b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ba1566636b, replyNumber=0, likeNumber=89, createdTime=2015-11-13, rootId=0, userName=lilili1116, userId=03a637065096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ba1566636b, moduleTitle=JCO：埃罗替尼不能延长NSCLC无病生存时间, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ba1566636b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755994, encodeId=32561e55994eb, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, objectTitle=JCO:辅助激素疗法可改善上皮性卵巢癌患者生存时间, objectType=article, longId=56796, objectId=e6ba56e969e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6ba56e969e, replyNumber=0, likeNumber=76, createdTime=2016-01-20, rootId=0, userName=lilili1116, userId=03a637065096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6ba56e969e, moduleTitle=JCO:辅助激素疗法可改善上皮性卵巢癌患者生存时间, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6ba56e969e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755998, encodeId=a1691e55998ad, content=<a href='/topic/show?id=2e3269002f5' target=_blank style='color:#2F92EE;'>#生存时间#</a>, objectTitle=JCO：高剂量干扰素α-2b治疗黑色素瘤并不延长生存时间, objectType=article, longId=63179, objectId=752d631e9a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=752d631e9a7, replyNumber=0, likeNumber=90, createdTime=2016-09-08, rootId=0, userName=lilili1116, userId=03a637065096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=752d631e9a7, moduleTitle=JCO：高剂量干扰素α-2b治疗黑色素瘤并不延长生存时间, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=752d631e9a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存时间

2020-05-29

lilili1116 (审核中...)

前往app查看评论内容

#生存时间#

我不要你觉得，我要我觉得！即使自评，有心理困扰的乳腺癌患者生存时间缩短28年！死亡风险上升45%！

2022-07-04

lilili1116 (审核中...)

前往app查看评论内容

#生存时间#

中国患者研究：祸福相倚！用免疫检查点抑制剂有皮肤免疫相关不良事件，生存时间竟或翻倍？

2022-08-26

lilili1116 (审核中...)

前往app查看评论内容

#生存时间#

ASCO2022：纳武利尤单抗能显著增加高危肌层浸润性尿路上皮癌患者无病生存时间

2022-06-10

lilili1116 (审核中...)

前往app查看评论内容

#生存时间#

Liver Cancer：肝细胞癌患者免疫检查点抑制剂（ICI）治疗期间使用抗生素缩短生存时间

2022-07-16

lilili1116 (审核中...)

前往app查看评论内容

#生存时间#

Clin Cancer Res：nivolumab + ipilimumab对比舒尼替尼治疗晚期肾细胞癌（aRCC）患者后的无治疗生存时间（TFS）对比：来自Check- Mate 214研究结果

2022-06-04

lilili1116 (审核中...)

前往app查看评论内容

#生存时间#

Clin Trans Gastroenterology：性别相关的基因表达改变与食管癌的生存时间相关

2021-08-25

lilili1116 (审核中...)

前往app查看评论内容

#生存时间#

Chest：过敏性肺炎的影像学表型与不同生存时间和肺功能轨迹相关

2018-10-02

lilili1116 (审核中...)

前往app查看评论内容

#生存时间#

JAMA Oncology：CD8+肿瘤浸润淋巴细胞与卵巢癌生存时间的关系

2018-11-06

lilili1116 (审核中...)

前往app查看评论内容

#生存时间#

Heart：主动脉瓣置换术会延长严重返流和低射血分数患者的生存时间吗？

2018-08-17

lilili1116 (审核中...)

前往app查看评论内容

#生存时间#

J Clin Periodontol：利用生存时间预测牙周预后的预测模型

2018-07-02

lilili1116 (审核中...)

前往app查看评论内容

#生存时间#

Gut：IRTKS与胃癌进展和患者生存时间相关

2017-08-12

lilili1116 (审核中...)

前往app查看评论内容

#生存时间#

β受体拮抗剂是否可以延长晚期HER2阴性乳腺癌患者生存时间？

2018-06-25

lilili1116 (审核中...)

前往app查看评论内容

#生存时间#

Clin Gastroenterol H：雌激素替代疗法降低女性肝癌患者的风险和增加生存时间！

2017-06-15

lilili1116 (审核中...)

前往app查看评论内容

#生存时间#

J CLIN ONCOL：阿司匹林等非甾体类抗炎药物的使用时间与结直肠癌患者的肿瘤标志物与生存时间之间的关系

2017-10-12

lilili1116 (审核中...)

前往app查看评论内容

#生存时间#

Nature：生存时间延长67%！科学家瞄准肿瘤微环境，找到治疗胶质母细胞瘤的关键基因！

2018-01-23

lilili1116 (审核中...)

前往app查看评论内容

#生存时间#

JAMA Surg：辅助化疗与胃癌患者生存时间的关系

2017-08-11

lilili1116 (审核中...)

前往app查看评论内容

#生存时间#

J CLIN ONCOL：肥胖肾癌患者生存时间更久？！

2017-07-28

lilili1116 (审核中...)

前往app查看评论内容

#生存时间#

JCO：埃罗替尼不能延长NSCLC无病生存时间

2015-11-13

lilili1116 (审核中...)

前往app查看评论内容

#生存时间#

JCO:辅助激素疗法可改善上皮性卵巢癌患者生存时间

2016-01-20

lilili1116 (审核中...)

前往app查看评论内容

#生存时间#

JCO：高剂量干扰素α-2b治疗黑色素瘤并不延长生存时间

2016-09-08

科室
- - 订阅+
  - 更多科室
工具
服务